An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects with Major Depressive Disorder
Brief description of study
This study is a multi-center, open-label trial to evaluate the long-term safety and efficacy of AXS-05 in subjects with major depressive disorder (MDD).
Eligible subjects must have completed a prior MDD study with AXS-05 (AXS-05-301 or AXS-05-MDD-301) immediately prior to enrollment in this study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Depressive Disorder,Depression,Mental Health,Depressed state
-
Age: - 99 Years
-
Gender: All
Updated on
09 Aug 2022.
Study ID: 833716